Literature DB >> 6650180

Differences between binding affinities of some antimuscarinic drugs in the parotid gland and those in the urinary bladder and ileum.

L Nilvebrant, B Sparf.   

Abstract

Possible differences between the muscarinic receptors in the guinea pig urinary bladder and those in the ileum and the parotid gland were investigated, using a receptor binding technique. The affinities of 18 antimuscarinic drugs were indirectly derived from the ability to inhibit the receptor-specific binding of the radioligand (-)3H-QNB. The Hill coefficients were close to unity which indicated that the drugs were bound to apparently uniform populations of receptors within each tissue. In contrast to traditional muscarinic antagonists, four drugs - namely, oxybutynine, dicyclomine, benzhexol and pirenzepine - bound with a significantly higher affinity in the parotid gland than in the urinary bladder and ileum. A tendency towards reversed selectivity was found for secoverine. Thus, the present results further support the hypothesis that differences in muscarinic receptors between tissues exist, e.g. smooth muscle compared with parotid gland, which can be detected only by certain antimuscarinic drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6650180     DOI: 10.1111/j.1600-0773.1983.tb03427.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  5 in total

1.  Regulation of bladder muscarinic receptor subtypes by experimental pathologies.

Authors:  M R Ruggieri; A S Braverman
Journal:  Auton Autacoid Pharmacol       Date:  2006-07

2.  Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.

Authors:  D Bleakman; R J Naftalin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

3.  Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

Authors:  P Wang; G R Luthin; M R Ruggieri
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

4.  Competitive and non-competitive antagonism exhibited by 'selective' antagonists at atrial and ileal muscarinic receptor subtypes.

Authors:  R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

5.  Direct binding studies on ileal and cardiac muscarinic receptors.

Authors:  A D Michel; R L Whiting
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.